Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Kyntra Bio Inc (KYNB) vs TransCode Therapeutics Inc. (RNAZ)

Kyntra Bio Inc and TransCode Therapeutics Inc. are both Biotechnology companies. Kyntra Bio Inc and TransCode Therapeutics Inc. are of similar size ($28.3M and $27.9M). TransCode Therapeutics Inc. has negative trailing earnings, so its P/E is not meaningful; Kyntra Bio Inc trades at 0.2×. Kyntra Bio Inc has the higher net margin (3,967.8% vs 0.00%) and the higher return on invested capital (0.00% vs 0.00%). Across the 11 metrics below, Kyntra Bio Inc leads on 7 and TransCode Therapeutics Inc. on 4.

Valuation

Metric KYNB RNAZ Biotechnology median
P/E 0.15 n/m 7.88
P/S 6.08 n/m 11.47
P/B n/m n/m 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m 0.15 0.74
EV/Sales 18.18 n/m 10.73
Earnings yield 652.74% (3,098.82%) (28.84%)
Free cash flow yield (135.59%) (1,398.93%) (23.03%)

Profitability

Metric KYNB RNAZ Biotechnology median
Gross margin 6.28% 0.00% 65.16%
Operating margin (1,089.78%) 0.00% 0.00%
Net margin 3,967.77% 0.00% 0.00%
Free cash flow margin (824.19%) 0.00% 0.00%
Return on equity (157.83%) 429.61% (57.72%)
Return on assets 131.26% (58.12%) (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric KYNB RNAZ Biotechnology median
Revenue growth (TTM) (37.15%) — 5.64%
EPS growth (last fiscal year) 478.08% 96.02% —
Revenue growth, 5-year CAGR (48.42%) — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric KYNB RNAZ Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 2.69 1.97 4.73
Net debt to EBITDA 1.97 0.64 0.96

Dividend

Metric KYNB RNAZ Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric KYNB RNAZ Biotechnology median
Market cap 28.34m 27.94m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack